Explore groundbreaking studies in medicinal chemistry, drug design methodologies, and therapeutic discovery
Discover how LXM-10, a novel spirocyclopiperazinium compound, targets inflammation through the cholinergic anti-inflammatory pathway with dual-receptor activation.